This post is presented by our media partner Cannabis News Wire
View the original article here.
Germany recently passed a new law that decriminalizes marijuana possession and cultivation for personal use, permitting individuals over the age of 18 to possess up to 25 grams of marijuana and cultivate up to three plants for personal use. Beginning in July 2024, German citizens can also join cannabis grower’s associations or not-for-profit social clubs that focus on the collective cultivation of cannabis for members’ benefit.
In contrast to Germany’s progressive stance, the UK government maintains its support for cannabis prohibition, which sets it apart from several nations, including certain U.S. states, Canada and Malta.
One of the primary arguments put forth by UK authorities in favor of prohibition is the concern over the potential negative impact of marijuana on mental health. While research has extensively explored the relationship between marijuana usage and mental-health issues such as psychosis, it has been difficult to demonstrate a clear causal association because of ethical concerns.
However, studies have shown a notable correlation between psychosis and marijuana use, suggesting that certain individuals may be more susceptible to developing psychotic symptoms due to marijuana consumption. Research indicates that the incidence of psychosis among marijuana users remains relatively low compared to the overall number of individuals using the substance. For instance, one study estimated that preventing one case of psychosis would require deterring about 40,000 cannabis users.
Decriminalizing marijuana could yield various public health advantages in the United Kingdom, particularly concerning tobacco use. Many marijuana users in the UK use it together with tobacco, inadvertently exposing themselves to the well-known health risks associated with tobacco, including cancer, stroke and heart disease.
However, the illegality of marijuana in the UK complicates efforts by public-health organizations to intervene effectively. Germany, on the other hand, has a thorough public-health education campaign that aims to educate people about the dangers of cannabis usage. This contrasts with the lack of quality control and information in illicit markets where cannabis remains prohibited.
Notably, political parties such as the Conservatives and Labor have demonstrated little willingness to decriminalize marijuana despite the substance being widely used in the region. Surveys showing public support for current policies may have an impact on this hesitation.
Moving beyond decriminalization to legalization could offer substantial financial benefits. Estimates suggest that legalizing marijuana in Germany could generate annual tax revenue of approximately $4 billion, similar to the regulated market in Canada. Given the financial strain on public services, particularly the NHS, persisting with marijuana prohibition in the UK represents a missed opportunity for public health and is a costly policy choice.
The step that Germany has taken in decriminalizing marijuana could trigger a domino effect round the bloc and create a robust international market for companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), which may be interested in growing their footprint outside their primary North American market.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
This post was originally published by our media partner here.
